Vanguard Capital Opportunity Fund Admiral Shares
$269.41-$0.02 (-0.01%)
Vanguard Capital Opportunity Fund Admiral Shares’s quoted price sits in the upper half of its reported 52-week range, 4.85% below the high.
NASDAQ · VSMGX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:10 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Vanguard LifeStrategy Moderate Growth Fund’s quoted price sits in the upper half of its reported 52-week range, 1.92% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Vanguard LifeStrategy Moderate Growth Fund’s forward annual dividend is $0.72 per share, paid semi-annual. The forward yield is 1.97% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Vanguard LifeStrategy Moderate Growth Fund is part of a suite of comprehensive, low-cost investment options offering a diversified, index-based portfolio all within a single fund. This series features a fixed asset allocation approach, with four distinct funds available, each tailored to different risk profiles. Specifically, this Moderate Growth Fund is designed to pursue capital growth while also generating a low to moderate stream of income. Its strategy involves a consistent allocation of 60% to equities, which includes international stocks, and 40% to fixed-income investments, also incorporating global bonds. This fund is ideal for individuals with a long-term investment horizon who are prepared to accept the natural fluctuations of the stock market. It's crucial to understand that all LifeStrategy funds are subject to the inherent risks of their underlying holdings. A significant change is scheduled for May 12, 2026, when the fund's name will change from the Vanguard LifeStrategy Moderate Growth Fund to the Vanguard LifeStrategy 60/40 Fund. However, this alteration is purely nominal; its investment objectives, strategies, and operational policies will remain unchanged.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:16 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$269.41-$0.02 (-0.01%)
Vanguard Capital Opportunity Fund Admiral Shares’s quoted price sits in the upper half of its reported 52-week range, 4.85% below the high.
$19.93+$0.15 (+0.76%)
Bridge Builder Large Cap Value Fund’s quoted price sits in the upper half of its reported 52-week range, 0.99% below the high.
$15.78-$0.02 (-0.13%)
Bridge Builder International Equity Fund’s quoted price sits in the upper half of its reported 52-week range, 4.31% below the high.
$25.53+$0.21 (+0.83%)
Vanguard Windsor Fund Investor Shares’s quoted price sits in the upper half of its reported 52-week range, 0.16% below the high.
$57.08+$0.50 (+0.88%)
T. Rowe Price New Horizons Fund’s quoted price sits in the upper half of its reported 52-week range, 7.4% below the high.
$25.60$0.00 (0.0%)
T. Rowe Price Retirement 2035 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.1% below the high.
$31.00+$0.05 (+0.16%)
Vanguard STAR Fund’s quoted price sits in the upper half of its reported 52-week range, 1.74% below the high.
$122.36+$1.41 (+1.17%)
Vanguard Explorer Fund Admiral Shares’s quoted price sits in the upper half of its reported 52-week range, 5.95% below the high.